Table 1.

Response by Baseline Characteristics

All Patients (n = 120)	RR (95% CI) 25% (18%–34%)	P Value* .0014
Tumor Type
Clear cell (n = 115)	26% (18%–35%)	.33
Non-clear cell (n = 5)	0% (0%–52%)
MSKCC Risk Group
Favorable (n = 21)	23% (7%–44%)	.89
Intermediate (n = 81)	25% (16%–36%)
Poor (n = 18)	31% (9%–61%)
UCLA Risk Group
Low (n = 10)	20% (3%–56%)	.27
Intermediate (n = 101)	27% (19%–37%)
High (n = 8)	0% (0%–37%)

Abbreviations: MSKCC, Memorial Sloan-Kettering Cancer Center; RR, relative risk; UCLA, University of California, Los Angeles.

Courtesy of David McDermott, MD, Boston, MA. Presented at the 2010 ASCO Annual Meeting; June 4–8, 2010; Chicago, Illinois.